Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older.
- People who have been clinically diagnosed with idiopathic Parkinson's disease (Parkinson's disease with no known external cause).
- People for whom a doctor is planning to start treatment with sublingual apomorphine (a medication placed under the tongue) for "OFF episodes" — periods when Parkinson's symptoms return or worsen between doses of regular medication.
- People who have not yet started the dose-adjustment or ongoing maintenance phase of sublingual apomorphine treatment.
- People who have given written consent to take part in the study.
Who may not be able to join:
- People who are currently taking part in another clinical trial involving an experimental drug.
- People who have been assessed by the investigator as having dementia or signs of cognitive (thinking or memory) decline.
- People who have a history of a psychotic disorder (a condition involving a loss of contact with reality, such as hallucinations or delusions).
- People who have any other medical reason that would make sublingual apomorphine unsuitable for them, as outlined in the medication's official prescribing guidelines (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jan Kassubek, Prof Dr med, Praxis für Neurologie und Geriatrie (Ulm)
Phone: +351229866100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identify the most frequent dose used after dose-adjustment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.